TLC is a biopharmaceutical company that focuses on the research, development and commercialization of drugs for infectious diseases... Read more
TLC is a biopharmaceutical company that focuses on the research, development and commercialization of drugs for infectious diseases... Read more
News
Dec 25, 2024
Pharamceutical Technology
Taiwan Liposome Company, Ltd.: Dexamethasone sodium phosphate SR by Taiwan Liposome for Osteoarthritis Pain: Likelihood of Approval
Dec 27, 2023
Yahoo
Taiwan Liposome Company, Ltd.: TLC to Present at the 42nd Annual JP Morgan Healthcare Conference
Nov 20, 2023
centralcharts
Press Release: Taiwan Liposome Company, Ltd. : Highlights of Dr. David Hunter's Oral Presentation at ACR's Late Breaking Abstracts Session
Nov 08, 2023
StreetInsider
Press Release: Taiwan Liposome Company, Ltd. : TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACR
Jun 14, 2022
Pharmabiz
Taiwan Liposome Company, Ltd.: Endo inks agreement with Taiwan Liposome Company to commercialize TLC599 to treat osteoarthritis knee pain
Mar 07, 2022
FirstWord Pharma
Taiwan Liposome Company, Ltd.: TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & Therapy
Sep 09, 2021
MarketScreener
Taiwan Liposome Company, Ltd.: Taiwan Liposome : TLC to Present at Upcoming Virtual Investor Conferences
Sep 08, 2021
MarketScreener
Taiwan Liposome Company, Ltd.: Taiwan Liposome : TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares (Form 6-K)
Aug 27, 2021
MarketScreener
Taiwan Liposome Company, Ltd.: Taiwan Liposome : ANNUAL GENERAL MEETING MINUTES (Form 6-K)
Aug 12, 2021
MarketScreener
Taiwan Liposome Company, Ltd.: Taiwan Liposome : TLC Reports Second Quarter 2021 Financial Results and Provides Business Update (Form 6-K)
Taiwan Liposome Company, Ltd. Competitors
1
2
3
4
5
6
7
8
9
10